Strengthening Regulatory Systems to Improve Global Food and Medical Product Quality and Safety (U01) Clinical Trials Not Allowed
ArchivedFood and Drug Administration
Description
This Cooperative Agreement represents the continuation and further expansion of well-established collaborations between the World Health Organization (WHO) and the Food and Drug Administration (FDA), in support of data-driven and science-based public health strategies and approaches that align well with FDA domestic and global goals. This cooperative agreement is expected to contribute to the knowledge base of the current food and medical products safety globally and address specific challenges in the global efforts to ensure safety of such products. Relevant strategies include: 1) developing global norms and standards; 2) articulating evidence-based policy options, including those relating to regulatory systems performance; and 3) providing technical support to national regulatory authorities and governments through systems strengthening efforts.
Who can apply
- Others
Contact
Zahara Graves <br/>Grantor
zahara.graves@fda.hhs.gov
- PostedDec 11, 2023
- ClosesMar 31, 2024
- Award ceiling$750,000
- Program funding$750,000
- Expected awards1
- CFDA93.103
Pro insight
Edit and export this grant’s proposal template, plus deadline reminders, similar-grant suggestions, and funder history — all available with Pro.
Unlock with Pro